DataRobot Collaborates with IMDA to Make LLM Evaluation More Accessible to AI Builders with Project Moonshot
New framework and set of capabilities for benchmarking and red teaming AI evaluation SINGAPORE--(BUSINESS WIRE)--DataRobot,…
2 years ago
Wire Stories
ROBOTWORLD 2024 Presents Early Application Discount Promotions Until June
SEOUL, South Korea--(BUSINESS WIRE)--#KINTEX--ROBOTWORLD 2024, focusing on robotics from A to Z, is offering an…
2 years ago
Stampede Gold Comes Charging Onto Juicy Stakes Casino
What’s on offer online this week SYDNEY--(BUSINESS WIRE)--Out with the old and in with the…
2 years ago
Long-term future for New Zealand’s Tiwai Point aluminium smelter secured with new power deals
MELBOURNE, Australia--(BUSINESS WIRE)--New Zealand Aluminium Smelters (NZAS) has signed 20-year electricity arrangements that secure the…
2 years ago
Yatra Online, Inc. Announces Results for the Three Months and Year Ended March 31, 2024
GURUGRAM, India & NEW YORK--(BUSINESS WIRE)--$YTRA #AirTicketing--Yatra Online, Inc. (NASDAQ: YTRA) (the “Companyâ€), India’s leading…
2 years ago
Everybody Loves Languages Reports Financial Results for the First Quarter Ended March 31, 2024
TORONTO--(BUSINESS WIRE)--Everybody Loves Languages Corp. (“ELLâ€) (TSX-V: ELL; OTC: LMDCF; FSE: LIMA), www.everybodyloveslanguages.com, an edtech…
2 years ago
AEye CEO Matt Fisch to Keynote at Auto Lidar Tech Conference in Suzhou, China
Event hosted by DVN and Enmore scheduled for June 21, 2024 DUBLIN, Calif.--(BUSINESS WIRE)--AEye, Inc.…
2 years ago
Asia Pacific Prefabricated Construction Industry Report 2023-2027: Rising Inflation and Subsequent Surge in Material Prices to Support Growth – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Prefabricated Construction Industry Business and Investment Opportunities Databook - 100+ KPIs,…
2 years ago
Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC in China
Unprecedented: Ivonescimab Is the First Drug to Achieve Clinically Meaningful Benefit over Pembrolizumab in Randomized…
2 years ago
China Intelligent Driving Fusion Algorithm Research Report 2024: Sparse Algorithms, Temporal Fusion and Enhanced Planning and Control Become the Trend – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "China Intelligent Driving Fusion Algorithm Research Report, 2024" report has been added to…
2 years ago